ArticleClinical ophthalmology (Auckland, N.Z.)2025
Comparison of Ahmed Glaucoma Valve Implantation Alone Versus Combined with Phacoemulsification in Chinese Primary Open-Angle Glaucoma.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy and safety of ultrasound cycloplasty versus ahmed glaucoma valve for neovascular glaucoma.BMC ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To compare the surgical outcomes of Ahmed glaucoma valve (AGV) implantation and combined AGVwith phacoemulsification (Phaco-AGV) in Chinese patients with primary open-angle glaucoma (POAG). Methods: A total of 43 eyes followed up for 2 years were enrolled. The primary outcome was the success rate. The success rate was defined as an IOP of 5-21 mmHg (success rate 1) or 5-18 mmHg (success rate 2), and an IOP reduction of more than 20% with (qualified) or without (complete) glaucoma medications. The secondary outcomes included IOP, glaucoma medications, and complications. Results: Eighteen eyes underwent AGV and 25 eyes underwent phaco-AGV. There were no differences in the preoperative IOP (25.7 ± 10.7 mmHg vs 26.3 ± 6.2 mmHg, P<0.05) and medications (2.1 ± 1.4 vs 1.6 ± 0.8, P<0.05) between the two groups. The complete success rate 1 in the Phaco-AGV group was higher than that in the AGV group at the 2-year (60.0% vs 22.2%, P<0.05) follow-up. The qualified and complete success rates 2 in the Phaco-AGV group were both higher than those in the AGV group at the 2-year follow-up (all P < 0.05). Patients in the Phaco-AGV group showed significantly lower postoperative IOP at 3 months (P<0.05), used fewer glaucoma medications at month-3, month-6 and year-2 visits, experienced less encapsulated blebs than those in the AGV group (P<0.05). Conclusion: The surgical outcomes of phaco-AGV showed higher success rates and fewer complications than those of AGV in this 2-year study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.